5-methyl-6-phenyl-4,5-dihydro-2H-pyridazin-3-one derivative
US-10611731-B2 · Apr 7, 2020 · US
having less than three double bonds between ring members or between ring members and non-ring members
having less than three double bonds between ring members or between ring members and non-ring members · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D237/04 |
| Official title | having less than three double bonds between ring members or between ring members and non-ring members |
| Display label | having less than three double bonds between ring members or between ring members and non-ring members |
| Total patents | 114 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 4 |
| 2016 | 19 |
| 2017 | 14 |
| 2018 | 15 |
| 2019 | 7 |
| 2020 | 12 |
| 2021 | 8 |
| 2022 | 5 |
| 2023 | 10 |
| 2024 | 10 |
| 2025 | 7 |
| 2026 | 3 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Covalent inhibitors of kras g12c
US-2019389796-A1 · Dec 26, 2019 · US
Compositions, methods, and systems for the synthesis and use of imaging agents
US-10500293-B2 · Dec 10, 2019 · US
Triazolopyrazine
US-2019240219-A1 · Aug 8, 2019 · US
Neprilysin inhibitors
US-10336773-B2 · Jul 2, 2019 · US
Substituted [1,2,4]triazolo[4,3-a]pyrazines as BRD4 inhibitors
US-10328074-B2 · Jun 25, 2019 · US
Covalent inhibitors of kras G12C
US-10273207-B2 · Apr 30, 2019 · US
5-methyl-6-phenyl-4,5-dihydro-2h-pyridazin-3-one derivative
US-2019023662-A1 · Jan 24, 2019 · US
Compositions, methods, and systems for the synthesis and use of imaging agents
US-2018318456-A1 · Nov 8, 2018 · US
Dihydropyridazine-based antioxidants and uses thereof
US-2018244820-A1 · Aug 30, 2018 · US
Compounds And Compositions For The Treatment Of Cancer
US-2018244629-A1 · Aug 30, 2018 · US
Pyrrolidine amide compounds as histone demethylase inhibitors
US-10022354-B2 · Jul 17, 2018 · US
Neprilysin inhibitors
US-2018194776-A1 · Jul 12, 2018 · US
Covalent inhibitors of kras g12c
US-2018162812-A1 · Jun 14, 2018 · US
Levosimendan compound for preventing or treating tau-related diseases
US-9962384-B1 · May 8, 2018 · US
Neprilysin inhibitors
US-2018105503-A1 · Apr 19, 2018 · US
Inhibitors of histone deacetylase
US-2018099977-A1 · Apr 12, 2018 · US
Covalent inhibitors of K-Ras G12C
US-9926267-B2 · Mar 27, 2018 · US
Compositions, methods, and systems for the synthesis and use of imaging agents
US-9919064-B2 · Mar 20, 2018 · US
Pyridazones and triazinones for treatment and prophylaxis of hepatitis B virus infection
US-9902701-B2 · Feb 27, 2018 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D237/04?
- CPC C07D237/04 is the Cooperative Patent Classification code for “having less than three double bonds between ring members or between ring members and non-ring members.”
- How many patents are filed under CPC C07D237/04 (having less than three double bonds between ring members or between ring members and non-ring members)?
- Our database includes 114 publications tagged with this CPC code.
- Is patent activity under CPC C07D237/04 growing?
- Publication counts under this code: 10 in 2024 vs 7 in 2025 (latest complete years).